Close

Thermo Fisher Scientific (TMO) Reports In-Line Q3 EPS; Cuts FY11 Outlook

October 26, 2011 6:23 AM EDT
Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $1.07, in-line with the analyst estimate of $1.07. Revenue for the quarter came in at $2.97 billion versus the consensus estimate of $3 billion.

Thermo Fisher Scientific sees FY2011 EPS of $4.11-$4.17, versus prior guidance of $4.15-$4.25 and the consensus of $4.20. Sees FY2011 revenue of $11.62-$11.70 billion, versus prior guidance of $11.79-$11.89 billion and the consensus of $11.83 billion.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Guidance